Hi Adam, do you imagine that the S&P 500 is rising too quickly, as we are unsure about the timeline for a vaccine- even with Project Warp Speed? Or, do you think that the market will remain a little more stable, even if possibly bad news about the vaccine timeline begins to leak out?
Is there a correlation in the amount of surfactant in the lungs and someone's weight- implying a greater connection between COVID-19 and obesity, or the the rate of new infections per day irrelevant to the USA obesity rate?
Hi Karl, first of all, thank you for your article. I was wondering how you see the COVID-19 Pandemic specifically affecting private pharma/biotech companies moving forward- as they raise future rounds of money? Do you imagine the same effect on these companies compared to private companies in other sectors, or do you imagine that VC Funds will continue to pour money into these smaller private pharma/biotech companies, with the global threat of other viruses or the return of the novel corona virus?
Latest Comments
Stocks Soar Despite Pharma Giant CEO Questioning Vaccine Timelines
Hi Adam, do you imagine that the S&P 500 is rising too quickly, as we are unsure about the timeline for a vaccine- even with Project Warp Speed? Or, do you think that the market will remain a little more stable, even if possibly bad news about the vaccine timeline begins to leak out?
Trumpdesivir: Operation Warp Speed, “Engage.”
Is there a correlation in the amount of surfactant in the lungs and someone's weight- implying a greater connection between COVID-19 and obesity, or the the rate of new infections per day irrelevant to the USA obesity rate?
Making Sense Of Pandemic Valuations
Hi Karl, first of all, thank you for your article. I was wondering how you see the COVID-19 Pandemic specifically affecting private pharma/biotech companies moving forward- as they raise future rounds of money? Do you imagine the same effect on these companies compared to private companies in other sectors, or do you imagine that VC Funds will continue to pour money into these smaller private pharma/biotech companies, with the global threat of other viruses or the return of the novel corona virus?